Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Orange Book Blog: At the Intersection of Patent Law and FDA Law
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: Orange Book Blog: At the Intersection of Patent Law and FDA LawIQPC "Optimising Pharmaceutical Patent Lifecycles" Conference, London, April 29-30
By Aaron Barkoff
Legal IQ, a division of IQPC, will be holding a highly interactive two-day conference, "Optimising Pharmaceutical Patent Lifecycles," in London, April 29-30. The conference will focus on how to maximize product revenues and yet avoid anti-competitive issues through strategic patent lifecycle management.
Featuring seventeen international experts, the conference will cover hot topics such as how to maintain a competitive advantage by integrating legal and commercial strategies to extend product lifecycles, how to update patent strategies by assessing the implications of current U.S. and European case law, how to prevent competition law violations and how to maximize the commercial value of patents by strategically managing the interplay between generics and innovators.
The conference features two practical tutorials ("P.I.T. Stop" sessions), led by experts from Bristows and Simmons & Simmons, which will allow attendees to discuss and work through common industry problems guided by the experts' perspectives. The main focus will be on building a commercially sound patent lifecycle management strategy and reassessing the impact that patent practices have on competition law positions in Europe and the U.S.
The conference is specifically designed to answer pressing questions from top figures at EPO, UK IPO, Indian PO and USPTO, provide practical lessons in how to apply the key patent lifecycle extension strategies, and ensure that attendees maximize the efficiency of potential collaborations between innovators and generics.
For more information or the register, please visit the conference website.
Full post as published by Orange Book Blog: At the Intersection of Patent Law and FDA Law on March 26, 2008 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Great-West Lifeco Must Pay $456 Million In London Life Class Action
Great-West Lifeco Must Pay $456 Million In London Life Class Action
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment

ACI Maximizing Pharmaceutical Patent Lifecycles Conference
Pharmaceutical Patent Law: A Prescription for Success in Challenging Times
Upcoming Patent Events: Pharmaceutical and Biotech Patent Opinion Writing
Maximizing Pharmaceutical Patent Life Cycles
C5 Biotech Patenting Conference







